Powder: -20°C for 3 years | In solvent: -80°C for 1 year
OS-3-106 is a novel arylamide phenylpiperazines, as partial agonists at the D3R in the adenylyl cyclase inhibition assay.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 47.00 | |
10 mg | In stock | $ 84.00 | |
25 mg | In stock | $ 178.00 | |
50 mg | In stock | $ 312.00 | |
100 mg | In stock | $ 533.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 63.00 |
Description | OS-3-106 is a novel arylamide phenylpiperazines, as partial agonists at the D3R in the adenylyl cyclase inhibition assay. |
In vitro | The effect of OS-3-106 (10 mg/kg) on the dose-response function of cocaine self-administration.?OS-3-106 decreased cocaine and sucrose reinforcement rates, increased latency to first response for cocaine but not sucrose, and downshifted the cocaine self-administration dose-response function.?Thish compounds blocked a D3R-mediated behavior. |
Molecular Weight | 450.6 |
Formula | C25H30N4O2S |
CAS No. | 1580000-17-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.51 mg/mL (10 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
OS-3-106 1580000-17-4 GPCR/G Protein Neuroscience Dopamine Receptor Inhibitor inhibit HEK 293 cells self-administration arylamide phenylpiperazine OS 3 106 psychostimulant addiction cocaine sucrose OS3106 inhibitor